138 related articles for article (PubMed ID: 32427701)
1. Fixed 30 mCi 131I-iodine therapy without recombinant human thyroid-stimulating hormone stimulation as an attractive therapeutic alternative in nontoxic nodular goiter.
Riguetto CM; Miguel VP; Pavin EJ; Amorim BJ; Ramos CD; Zantut-Wittmann DE
Nucl Med Commun; 2020 Aug; 41(8):727-732. PubMed ID: 32427701
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine therapy for multinodular toxic goiter.
Nygaard B; Hegedüs L; Ulriksen P; Nielsen KG; Hansen JM
Arch Intern Med; 1999 Jun; 159(12):1364-8. PubMed ID: 10386513
[TBL] [Abstract][Full Text] [Related]
4. [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].
Pisarek M; Baczyk M; Gryczyńska M; Sowiński J
Endokrynol Pol; 2007; 58(1):18-26. PubMed ID: 17354201
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine for nontoxic multinodular goiter.
Huysmans D; Hermus A; Edelbroek M; Barentsz J; Corstens F; Kloppenborg P
Thyroid; 1997 Apr; 7(2):235-9. PubMed ID: 9133693
[TBL] [Abstract][Full Text] [Related]
6. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm.
Schiavo M; Bagnara MC; Camerieri L; Pomposelli E; Giusti M; Pesce G; Reitano C; Caputo M; Bagnasco M
Endocrine; 2015 Apr; 48(3):902-8. PubMed ID: 25151403
[TBL] [Abstract][Full Text] [Related]
8. Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone.
Paz-Filho GJ; Mesa-Junior CO; Olandoski M; Woellner LC; Goedert CA; Boguszewski CL; Carvalho GA; Graf H
Braz J Med Biol Res; 2007 Dec; 40(12):1661-70. PubMed ID: 17934635
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine treatment of multinodular non-toxic goitre.
Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Søe-Jensen P; Hansen JM
BMJ; 1993 Oct; 307(6908):828-32. PubMed ID: 8401123
[TBL] [Abstract][Full Text] [Related]
10. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ
J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
13. Large, compressive goiters treated with radioiodine.
Huysmans DA; Hermus AR; Corstens FH; Barentsz JO; Kloppenborg PW
Ann Intern Med; 1994 Nov; 121(10):757-62. PubMed ID: 7944053
[TBL] [Abstract][Full Text] [Related]
14. Long-term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity.
Roque C; Santos FS; Pilli T; Dalmazio G; Castagna MG; Pacini F
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32320467
[TBL] [Abstract][Full Text] [Related]
15. [Autoimmunization and multinodular large toxic goiter therapy using repeated doses of 131I].
Pisarek M; Baczyk M; Gryczyńska M; Pietz L; Ziemnicka K; Sowiński J
Pol Arch Med Wewn; 2006 Jun; 115(6):545-50. PubMed ID: 17263226
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
[TBL] [Abstract][Full Text] [Related]
17. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
18. Extremely high doses of radioiodine required for treatment of Graves' hyperthyroidism: a case report.
Neto AM; Tambascia MA; Brunetto S; Ramos CD; Zantut-Wittmann DE
Cases J; 2009 Aug; 2():8479. PubMed ID: 19918435
[TBL] [Abstract][Full Text] [Related]
19. [Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery].
Dietlein M; Dederichs B; Kobe C; Theissen P; Schmidt M; Schicha H
Nuklearmedizin; 2006; 45(1):21-34; quiz N1-2. PubMed ID: 16493511
[TBL] [Abstract][Full Text] [Related]
20. [Radioiodine treatment of benign thyroid diseases].
Konrády A
Orv Hetil; 2006 Sep; 147(37):1783-9. PubMed ID: 17131798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
